New York, July 14, 2016 -- Moody's Investors Service commented that the announcement by the Competition and Markets Authority (CMA) that it would refer Acadia Healthcare Company's acquisition of Priory Group for a Phase 2 investigation is modestly credit negative. However, the development has no immediate impact on Acadia's ratings and outlook. Therefore, there is no change in Acadia's B1 Corporate Family Rating and stable outlook.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.